IPO Boutique

Ablynx NV IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Ablynx NV, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Ablynx NVABLX -
NASDAQ
$17.90-$19.08 $17.50 $17.8511.43 million ADSs10/25/2017
BofA Merrill Lynch, J.P. Morgan, Jefferies
Co-Manager(s):
Baird, Bryan Garnier & Co., Ladenburg Thalmann
Health Care
Filing(s):

Terms Added 2017-10-17
Filed 2017-10-02
Updated Terms 2017-10-20
Final Prospectus 2017-10-25



Ablynx NV Quote & Chart - Click for current quote - ABLX

About Ablynx NV (adapted from Ablynx NV prospectus):
They are a late-stage clinical biopharmaceutical company utilizing our proprietary Nanobody platform to develop treatments for a broad range of therapeutic indications with an unmet medical need. Their ordinary shares are listed on Euronext Brussels under the symbol 'ABLX'.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ABLX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved